Physician profile
Mark Schwartz
NPI 1245388131
$1,205.23
in general payments reported to CMS, 2019-2025
8 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $263 · 2022: $595 · 2023: $125 · 2024: $101 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $252.48 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $213.88 | 2022 | |
| Boston Scientific Corporation | $148.34 | 2021 | |
| Neurocrine Biosciences, INC. | $132.68 | 2022 | |
| Abbvie INC. | $124.78 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $120.25 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $111.49 | 2022 | |
| Abiomed | $101.33 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.